by jlohrconsulting | Sep 1, 2025 | Uncategorized
BMC Psychol. 2025 Aug 31;13(1):992. doi: 10.1186/s40359-025-03189-8. ABSTRACT BACKGROUND: The number of college students in need of treatment for depressive symptoms far outweighs the resources of most counseling centers due to rising health needs. It is necessary to...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
J Diabetes. 2025 Sep;17(9):e70151. doi: 10.1111/1753-0407.70151. ABSTRACT BACKGROUND: This meta-analysis aims to assess the association between exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and the incidence of suicidal behavior in patients with...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Yakugaku Zasshi. 2025;145(9):777-790. doi: 10.1248/yakushi.25-00086. ABSTRACT Cannabidiol (CBD) is an abundant phytocannabinoid extracted from Cannabis sativa L., along with delta-9-tetrahydrocannabinol. Plant-derived, highly purified CBD oral solution (100 mg/mL) is...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Age Ageing. 2025 Aug 29;54(9):afaf220. doi: 10.1093/ageing/afaf220. ABSTRACT BACKGROUND: Although recent evidence suggests that glycemic variability (GV) has a negative impact on neurodegeneration, its role in Parkinson’s disease (PD) remains unclear. OBJECTIVE:...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Gen Hosp Psychiatry. 2025 Aug 26;96:335-344. doi: 10.1016/j.genhosppsych.2025.08.013. Online ahead of print. ABSTRACT OBJECTIVE: Cognitive impairment is a significant aspect of bipolar disorder, affecting both emotional and non-emotional domains, leading to ongoing...
Recent Comments